IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
ELI:IBS - PTIBS0AM0008 - Common Stock
9.99 EUR
+0.13 (+1.32%)
IBS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 51 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and the financial health of IBS get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, IBS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
IBS had positive earnings in the past year.
IBS had a positive operating cash flow in the past year.
Of the past 5 years IBS 4 years were profitable.
In the past 5 years IBS always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 1.16%, IBS perfoms like the industry average, outperforming 45.10% of the companies in the same industry.
With a Return On Equity value of 2.54%, IBS perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
IBS's Return On Invested Capital of 3.13% is in line compared to the rest of the industry. IBS outperforms 41.18% of its industry peers.
IBS had an Average Return On Invested Capital over the past 3 years of 3.32%. This is significantly below the industry average of 11.20%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 2.54% | ||
| ROIC | 3.13% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
IBS has a Profit Margin (1.74%) which is comparable to the rest of the industry.
IBS's Profit Margin has declined in the last couple of years.
IBS has a Operating Margin of 4.61%. This is comparable to the rest of the industry: IBS outperforms 43.14% of its industry peers.
In the last couple of years the Operating Margin of IBS has declined.
IBS has a Gross Margin (49.59%) which is in line with its industry peers.
In the last couple of years the Gross Margin of IBS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.61% | ||
| PM (TTM) | 1.74% | ||
| GM | 49.59% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBS is destroying value.
IBS has less shares outstanding than it did 1 year ago.
IBS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IBS is higher compared to a year ago.
2.2 Solvency
IBS has an Altman-Z score of 1.97. This is not the best score and indicates that IBS is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.97, IBS perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
The Debt to FCF ratio of IBS is 6.53, which is on the high side as it means it would take IBS, 6.53 years of fcf income to pay off all of its debts.
IBS has a Debt to FCF ratio of 6.53. This is comparable to the rest of the industry: IBS outperforms 54.90% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that IBS is somewhat dependend on debt financing.
The Debt to Equity ratio of IBS (0.69) is better than 68.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 6.53 | ||
| Altman-Z | 1.97 |
ROIC/WACC0.51
WACC6.17%
2.3 Liquidity
IBS has a Current Ratio of 1.09. This is a normal value and indicates that IBS is financially healthy and should not expect problems in meeting its short term obligations.
IBS has a better Current ratio (1.09) than 62.75% of its industry peers.
A Quick Ratio of 1.01 indicates that IBS should not have too much problems paying its short term obligations.
IBS's Quick ratio of 1.01 is in line compared to the rest of the industry. IBS outperforms 56.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
The earnings per share for IBS have decreased strongly by -47.78% in the last year.
Measured over the past years, IBS shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.23% on average per year.
The Revenue has grown by 15.22% in the past year. This is quite good.
Measured over the past years, IBS shows a decrease in Revenue. The Revenue has been decreasing by -0.46% on average per year.
EPS 1Y (TTM)-47.78%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%-314.5%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%17.83%
3.2 Future
IBS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.23% yearly.
IBS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.79% yearly.
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.23%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.79%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 49.95 indicates a quite expensive valuation of IBS.
IBS's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of IBS to the average of the S&P500 Index (27.07), we can say IBS is valued expensively.
The Price/Forward Earnings ratio is 23.41, which indicates a rather expensive current valuation of IBS.
IBS's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.59. IBS is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.95 | ||
| Fwd PE | 23.41 |
4.2 Price Multiples
80.39% of the companies in the same industry are more expensive than IBS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.67 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as IBS's earnings are expected to grow with 20.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.36%
EPS Next 3Y20.34%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 7.22%, IBS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.97, IBS pays a better dividend. On top of this IBS pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.46, IBS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.22% |
5.2 History
On average, the dividend of IBS grows each year by 48.65%, which is quite nice.
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBS pays out 242.99% of its income as dividend. This is not a sustainable payout ratio.
The dividend of IBS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP242.99%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
ELI:IBS (9/10/2025, 3:53:37 PM)
9.99
+0.13 (+1.32%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners24.17%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap414.68M
Analysts83.33
Price Target11.82 (18.32%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.22% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP242.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)11.84%
Min Revenue beat(2)11.28%
Max Revenue beat(2)12.41%
Revenue beat(4)4
Avg Revenue beat(4)8.54%
Min Revenue beat(4)0.18%
Max Revenue beat(4)12.41%
Revenue beat(8)7
Avg Revenue beat(8)6.47%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.92%
PT rev (3m)-2.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)-36.9%
EPS NY rev (3m)-36.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)14.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.95 | ||
| Fwd PE | 23.41 | ||
| P/S | 0.84 | ||
| P/FCF | 8.67 | ||
| P/OCF | 5.26 | ||
| P/B | 1.23 | ||
| P/tB | 1.74 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.2
EY2%
EPS(NY)0.43
Fwd EY4.27%
FCF(TTM)1.15
FCFY11.54%
OCF(TTM)1.9
OCFY19.01%
SpS11.85
BVpS8.12
TBVpS5.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 2.54% | ||
| ROCE | 4.01% | ||
| ROIC | 3.13% | ||
| ROICexc | 4.09% | ||
| ROICexgc | 5.28% | ||
| OM | 4.61% | ||
| PM (TTM) | 1.74% | ||
| GM | 49.59% | ||
| FCFM | 9.73% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexcg growth 3Y-24.94%
ROICexcg growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 6.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 6.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 560.26% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 1.97 |
F-Score6
WACC6.17%
ROIC/WACC0.51
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.78%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%-314.5%
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.23%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%17.83%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.79%
EBIT growth 1Y0.48%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year399.89%
EBIT Next 3Y91.9%
EBIT Next 5Y57.35%
FCF growth 1Y-27.17%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y-26.24%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%